mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0009 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.006 |
mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.006 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.008 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.009 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.01 |
mRNA |
birinapant |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.01 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |